REQUEST A DEMO
Total
USD $0.00
Search more companies

The Arab Drug Company S.A.E (Egypt)

Main Activities: Medicinal and Botanical Manufacturing
Full name: The Arab Drug Company S.A.E Profile Updated: February 06, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Arab Pharmaceuticals (ADCO) specializes in the manufacture, packaging and distribution of pharmaceutical products and chemical solutions for human and veterinary use. ADCO produces different sizes and forms of medicines, including tablets, ampoules, syrups, solutions, capsules, sprays, creams, ointments. The company is ISO 9001 and ISO 14001 certified.

Legal Address
5 El Massanei Street,Al Amireya,P.O Box 1343
Cairo; Greater Cairo;

Contact Details: Purchase the The Arab Drug Company S.A.E report to view the information.

Website: http://www.adcopharma.com

Basic Information
Total Employees:
Purchase the The Arab Drug Company S.A.E report to view the information.
Outstanding Shares:
Purchase the The Arab Drug Company S.A.E report to view the information.
Financial Auditors:
Purchase the The Arab Drug Company S.A.E report to view the information.
Ratings:
Purchase the The Arab Drug Company S.A.E report to view the information.
Incorporation Date:
1964
Key Executives
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
10%
Subsidiaries
Company Performance
Financial values in the chart are available after The Arab Drug Company S.A.E report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EGP. Absolute financial data is included in the purchased report.
Net sales revenue
-3.65%
Total operating revenue
-3.45%
Operating profit (EBIT)
-14.12%
EBITDA
-16.55%
Net Profit (Loss) for the Period
-15.16%
Total assets
17.75%
Total equity
17.64%
Operating Profit Margin (ROS)
-2.73%
Net Profit Margin
-2.39%
Return on Equity (ROE)
-6.07%
Debt to Equity Ratio
8.6%
Quick Ratio
0.04%
Cash Ratio
-0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?